Genetically and phenotypically distinct pseudomonas aeruginosa cystic fibrosis isolates share a core proteomic signature

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Penesyan, Anahit ^a   Kumar, Sheemal S ^a   Kamath, Karthik ^a   Shathili, Abdulrahman M ^a   Venkatakrishnan, Vignesh ^a   Krisp, Christoph ^a   Packer, Nicolle H ^a   Molloy, Mark P ^a   Paulsen, Ian T ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHENAZINE; PROTEOME; PYOVERDINE; BACTERIAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM PILUS; BIOFILM; CARBON SOURCE; CONTROLLED STUDY; GENE SEQUENCE; GENOME ANALYSIS; MEMBRANE FORMATION; MOLECULAR PHYLOGENY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; ADULT; ANIMAL; CAENORHABDITIS ELEGANS; CYSTIC FIBROSIS; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PATHOGENICITY; PROTEOMICS; VIRULENCE; YOUNG ADULT;

ADULT; ANIMALS; BACTERIAL PROTEINS; BIOFILMS; CAENORHABDITIS ELEGANS; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROTEOMICS; PSEUDOMONAS AERUGINOSA; VIRULENCE; YOUNG ADULT;

EID: 84947293069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138527     Document Type: Article

References (67)

1. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001; 183(3):444-52.
2. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002; 34 (2):91-100.
3. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001; 138(5):699-704
4. Callaghan M, McClean S. Bacterial host interactions in cystic fibrosis. Curr Opin Microbiol. 2012; 15 (1):71-7. doi: 10.1016/j.mib.2011.11.001
5. Naughton S, Parker D, Seemann T, Thomas T, Turnbull L, Rose B, et al. Pseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung. PLoS One. 2011; 6(9).
6. Hare NJ, Solis N, Harmer C, Marzook NB, Rose B, Harbour C, et al. Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-Associated strain. BMC Microbiol. 2012; 12.
7. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000; 406 (6799):959-64.
8. Holloway BW. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol. 1955; 13(3):572-81.
9. Thaysen-Andersen M, Venkatakrishnan V, Loke I, Laurini C, Diestel S, Parker BL, et al. Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum. J Biol Chem. 2015; 290(14):8789-802. doi: 10.1074/jbc.M114.631622
10. Zerbino DR, Birney E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008; 18(5):821-9. doi: 10.1101/gr.074492.107
11. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013; 29(8):1072-5. doi: 10.1093/bioinformatics/btt086
12. Ludwig W, Strunk O, Westram R, Richter L, Meier H, Yadhukumar A, et al. ARB: A software environment for sequence data. Nucleic Acids Res. 2004; 32(4):1363-71.
13. Alikhan N, Petty NK, Ben Zakour NL, Beatson SA. BLAST Ring Image Generator (BRIG): Simple prokaryote genome comparisons. BMC Genomics. 2011; 12.
14. Darling ACE, Mau B, Blattner FR, Perna NT. Mauve: Multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 2004; 14(7):1394-403.
15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990; 215(3):403-10.
16. Lechner M, Findeib S, Steiner L, Marz M, Stadler PF, Prohaska SJ. Proteinortho: Detection of (Co-) orthologs in large-scale analysis. BMC Bioinformatics. 2011; 12.
17. Christensen BB, Sternberg C, Andersen JB, Palmer RJ Jr, Nielsen AT, Givskov M, et al. Molecular tools for study of biofilm physiology. Methods Enzymol. 1999; 310:20-42.
18. Murray TS, Kazmierczak BI. Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J Bacteriol. 2008; 190(8):2700-8.
19. Ballestriero F, Thomas T, Burke C, Egan S, Kjelleberg S. Identification of compounds with bioactivity against the nematode Caenorhabditis elegans by a screen based on the functional genomics of the marine bacterium Pseudoalteromonas tunicata D2. Appl Environ Microbiol. 2010; 76(17):5710-7. doi: 10.1128/AEM.00695-10
20. Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G, Thomashow LS. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J Bacteriol. 2001; 183(21):6454-65.
21. Owen JG, Ackerley DF. Characterization of pyoverdine and achromobactin in Pseudomonas syringae pv. phaseolicola 1448a. BMC Microbiol. 2011; 11.
22. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006; 1(6):2856-60. Epub 2007/04/05. doi: 10.1038/nprot.2006.468 .
23. Gillet LC, Navarro P, Tate S, Röst H, Selevsek N, Reiter L, et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012; 11(6). doi: 10.1074/mcp.O111.016717
24. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, et al. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 2011; 39(Database issue):D596-600. Epub 2010/10/12. doi: 10.1093/nar/gkq869
25. Vizcaino JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Rios D, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014; 32(3):223-6. Epub 2014/04/15. doi: 10.1038/nbt.2839
26. Caspi R, Altman T, Billington R, Dreher K, Foerster H, Fulcher CA, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 2014; 42(D1):D459-D71. doi: 10.1093/nar/gkt1103
27. Paley SM, Karp PD. The Pathway Tools cellular overview diagram and Omics Viewer. Nucleic Acids Res. 2006; 34(13):3771-8. doi: 10.1093/nar/gkl334
28. Bragonzi A, Cigana C, Lorè NI, Bernardini ML. Dampening host sensing and avoiding recognition in Pseudomonas aeruginosa pneumonia. J Biomed Biotechnol. 2011; 2011:852513. doi: 10.1155/2011/852513
29. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A. 2006; 103(22):8487-92.
30. Colvin KM, Irie Y, Tart CS, Urbano R, Whitney JC, Ryder C, et al. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol. 2012; 14(8):1913-28. doi: 10.1111/j.1462-2920.2011.02657.x
31. Wozniak DJ, Wyckoff TJO, Starkey M, Keyser R, Azadi P, O'Toole GA, et al. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci U S A. 2003; 100(13):7907-12.
32. West SA, Diggle SP, Buckling A, Gardner A, Griffin AS. The social lives of microbes. Annu Rev Ecol Evol Syst. 2007; 38:53-77.
33. West SA, Griffin AS, Gardner A, Diggle SP. Social evolution theory for microorganisms. Nat Rev Micro. 2006; 4(8):597-607. http://www.nature.com/nrmicro/journal/v4/n8/suppinfo/nrmicro1461-S1.html.
34. Griffin AS, West SA, Buckling A. Cooperation and competition in pathogenic bacteria. Nature. 2004; 430(7003):1024-7.
35. Drake D, Montie TC. Flagella, motility and invasive virulence of Pseudomonas aeruginosa. J Gen Microbiol. 1988; 134(1):43-52.
36. Lanyi B. Serological properties of Pseudomonas aeruginosa. II. Type-specific thermolabile (flagellar) antigens. Acta Microbiol Acad Sci Hung. 1970; 17(1):35-48. Epub 1970/01/01. .
37. Allison JS, Dawson M, Drake D, Montie TC. Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-Antigen flagellins. Infect Immun. 1985; 49(3):770-4
38. Arora SK, Bangera M, Lory S, Ramphal R. A genomic island in Pseudomonas aeruginosa carries the determinants of flagellin glycosylation. Proc Natl Acad Sci U S A. 2001; 98(16):9342-7. doi: 10.1073/pnas.161249198
39. Takeuchi K, Taguchi F, Inagaki Y, Toyoda K, Shiraishi T, Ichinose Y. Flagellin glycosylation island in Pseudomonas syringae pv. glycinea and Its role in host specificity. J Bacteriol. 2003; 185(22):6658-65.
40. Merino S, Tomas JM. Gram-negative flagella glycosylation. Int J Mol Sci. 2014; 15(2):2840-57. doi: 10. 3390/ijms15022840
41. Arora SK, Ritchings BW, Almira EC, Lory S, Ramphal R. The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun. 1998; 66(3):1000-7. Epub 1998/03/06.
42. Schulz BL, Sloane AJ, Robinson LJ, Prasad SS, Lindner RA, Robinson M, et al. Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology. 2007; 17(7):698-712. doi: 10.1093/glycob/cwm036
43. Venkatakrishnan V, Packer NH, Thaysen-Andersen M. Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis. Expert Rev Respir Med. 2013; 7(5):553-76. doi: 10.1586/17476348.2013.837752
44. Sajjan U, Reisman J, Doig P, Irvin RT, Forstner G, Forstner J. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992; 89(2):657-65. Epub 1992/02/01. doi: 10.1172/jci115632
45. Burrows LL. Pseudomonas aeruginosa twitching motility: Type IV pili in action. Annu Rev Microbiol. 2012; 66:493-520. doi: 10.1146/annurev-micro-092611-150055
46. Kus JV, Tullis E, Cvitkovitch DG, Burrows LR. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology. 2004; 150(5):1315-26.
47. Pierson Iii LS, Pierson EA. Metabolism and function of phenazines in bacteria: Impacts on the behavior of bacteria in the environment and biotechnological processes. Appl Microbiol Biotechnol. 2010; 86 (6):1659-70. doi: 10.1007/s00253-010-2509-3
48. Caldwell CC, Chen Y, Goetzmann HS, Hao Y, Borchers MT, Hassett DJ, et al. Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis. Am J Pathol. 2009; 175(6):2473-88. doi: 10.2353/ajpath.2009.090166
49. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988; 56(9):2515-7.
50. Courtney JM, Bradley J, McCaughan J, O'Connor TM, Shortt C, Bredin CP, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007; 42(6):525-32.
51. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr. 2007; 19(1):83-8.
52. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun. 2004; 72(7):4275-8.
53. Cezairliyan B, Vinayavekhin N, Grenfell-Lee D, Yuen GJ, Saghatelian A, Ausubel FM. Identification of Pseudomonas aeruginosa phenazines that kill Caenorhabditis elegans. PLoS Pathog. 2013; 9(1).
54. Meyer JM. Proverdines: Pigments, siderophores and potential taxonomic markers of fluorescent pseudomonas species. Arch Microbiol. 2000; 174(3):135-42.
55. De Vos D, De Chial M, Cochez C, Jansen S, Tümmler B, Meyer JM, et al. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: Prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol. 2001; 175 (5):384-8.
56. Nguyen AT, O'Neill MJ, Watts AM, Robson CL, Lamont IL, Wilks A, et al. Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung. J Bacteriol. 2014; 196(12):2265-76. doi: 10.1128/JB.01491-14
57. Konings AF, Martin LW, Sharples KJ, Roddam LF, Latham R, Reid DW, et al. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun. 2013; 81(8):2697-704. doi: 10.1128/IAI.00418-13
58. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Deziel E, Smith EE, et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol. 2007; 64(2):512-33.
59. Stintzi A, Evans K, Meyer JM, Poole K. Quorum-sensing and siderophore biosynthesis in Pseudomonas aeruginosa: LasR/lasI mutants exhibit reduced pyoverdine biosynthesis. FEMS Microbiol Lett. 1998; 166(2):341-5.
60. Wang M, Schaefer AL, Dandekar AA, Greenberg EP. Quorum sensing and policing of Pseudomonas aeruginosa social cheaters. Proc Natl Acad Sci U S A. 2015; 112(7):2187-91. doi: 10.1073/pnas. 1500704112
61. Czaran T, Hoekstra RF. Microbial communication, cooperation and cheating: Quorum sensing drives the evolution of cooperation in bacteria. PLoS One. 2009; 4(8):e6655. doi: 10.1371/journal.pone. 0006655
62. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med. 2011; 183(12):1674-9. doi: 10.1164/rccm.201009-1430OC
63. Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, et al. Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient. PLoS One. 2013; 8(4). doi: 10.1371/journal.pone.0060225
64. De Soyza A, Hall AJ, Mahenthiralingam E, Drevinek P, Kaca W, Drulis-Kawa Z, et al. Developing an international Pseudomonas aeruginosa reference panel. MicrobiologyOpen. 2013; 2(6):1010-23. doi: 10.1002/mbo3.141
65. Bradbury RS, Reid DWEC, Inglis TJJ, Champion AC. Decreased virulence of cystic fibrosis Pseudomonas aeruginosa in Dictyostelium discoideum. Microbiol Immunol. 2011; 55(4):224-30. doi: 10.1111/j.1348-0421.2011.00314.x
66. Jeukens J, Boyle B, Kukavica-Ibrulj I, Ouellet MM, Aaron SD, Charette SJ, et al. Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients. PLoS One. 2014; 9(2). doi: 10.1371/journal.pone.0087611
67. Lelong E, Marchetti A, Simon M, Burns JL, van Delden C, Köhler T, et al. Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model. Clin Microbiol Infect. 2011; 17(9):1415-20. doi: 10.1111/j.1469-0691.2010.03431.x